Russell Investments Group Ltd. lowered its position in shares of Blend Labs, Inc. (NYSE:BLND – Free Report) by 11.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 705,735 shares of the company’s stock after selling 94,893 shares during the period. Russell Investments Group Ltd. owned about 0.27% of Blend Labs worth $2,364,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in BLND. Lightspeed Management Company L.L.C. purchased a new position in shares of Blend Labs during the fourth quarter worth about $97,366,000. Whitebark Investors LP purchased a new position in shares of Blend Labs during the fourth quarter worth about $10,895,000. Deutsche Bank AG grew its holdings in shares of Blend Labs by 748.2% during the fourth quarter. Deutsche Bank AG now owns 1,203,511 shares of the company’s stock worth $5,067,000 after buying an additional 1,061,621 shares during the last quarter. Two Sigma Investments LP grew its holdings in shares of Blend Labs by 62.2% during the fourth quarter. Two Sigma Investments LP now owns 2,203,500 shares of the company’s stock worth $9,277,000 after buying an additional 844,962 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Blend Labs by 4.6% during the first quarter. Vanguard Group Inc. now owns 17,586,601 shares of the company’s stock worth $58,915,000 after buying an additional 775,091 shares during the last quarter. Hedge funds and other institutional investors own 52.56% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on the company. JMP Securities reissued a “market outperform” rating and set a $7.00 price target on shares of Blend Labs in a report on Wednesday, May 28th. Wall Street Zen raised Blend Labs from a “sell” rating to a “hold” rating in a report on Sunday, August 17th. The Goldman Sachs Group lowered their price target on Blend Labs from $5.60 to $4.80 and set a “buy” rating on the stock in a report on Monday, May 12th. Keefe, Bruyette & Woods lowered their price target on Blend Labs from $4.00 to $3.75 and set a “market perform” rating on the stock in a report on Friday, August 8th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and issued a $5.25 price objective on shares of Blend Labs in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $4.88.
Blend Labs Trading Down 2.4%
Shares of BLND opened at $3.59 on Tuesday. Blend Labs, Inc. has a twelve month low of $2.63 and a twelve month high of $5.53. The stock’s 50 day moving average is $3.36 and its two-hundred day moving average is $3.42. The firm has a market capitalization of $932.18 million, a PE ratio of -23.93 and a beta of 1.24.
Blend Labs (NYSE:BLND – Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.05). The business had revenue of $31.52 million during the quarter, compared to the consensus estimate of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. On average, sell-side analysts predict that Blend Labs, Inc. will post -0.19 EPS for the current year.
Insider Activity at Blend Labs
In other news, insider Brian Kneafsey sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $2.87, for a total transaction of $71,750.00. Following the sale, the insider owned 696,598 shares of the company’s stock, valued at $1,999,236.26. The trade was a 3.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Nima Ghamsari sold 311,886 shares of the business’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $2.90, for a total value of $904,469.40. Following the sale, the insider directly owned 5,754,051 shares in the company, valued at $16,686,747.90. This trade represents a 5.14% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 561,736 shares of company stock worth $1,739,383 in the last three months. Corporate insiders own 35.52% of the company’s stock.
Blend Labs Profile
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Recommended Stories
- Five stocks we like better than Blend Labs
- How to Use the MarketBeat Stock Screener
- 3 Biotech Catalysts Present Major Opportunity
- What Are Treasury Bonds?
- 3 Cheap Stocks That Shouldn’t Be This Low
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Why Sprouts Farmers Market is Buying $1 Billion of Its Own Stock
Want to see what other hedge funds are holding BLND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Blend Labs, Inc. (NYSE:BLND – Free Report).
Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.